Explore Vaccination Progress by U.S. State
With dozens of COVID-19 vaccines now in clinical trials, it is important to understand the accelerated timelines for development, the different types of vaccines available, and the facts related to vaccine safety and efficacy. Additionally, as vaccines are approved, we will track data on vaccination efforts.
An interactive tool from our vaccine experts that explores how a vaccine is developed and the differences between a typical timeline and an accelerated timeline.
This series of brief reports will shed light on COVID-19 vaccine development, allocation and deployment in the United States and globally. Topics will include ensuring the safety and efficacy of Covid-19 vaccines, principles for vaccine allocation, strategies for deployment and delivery of Covid-19 vaccines, vaccine confidence and demand, and the economics of Covid-19 vaccines.
By Gatien de Broucker, Salin Sriudomporn, Bryan Patenaude, Elizabeth Watts, Deborah Odihi, Cristina Garcia
COVID-19 VACCINE MATTERS: A blog series discussing the evolving science and policy of COVID-19 vaccines, led by internationally renowned experts in vaccine development, Dr. Larry Corey of the Univeristy of Washington, and Dr. Chris Beyrer of Johns Hopkins University.
Johns Hopkins University and the University of Washington hosted a high-level symposium, “The Scientific Integrity of COVID-19 Vaccine Efficacy Trials: From Clinical Trials to Public Allocation,” that explored complex issues, brought together leading voices in the field, and put forward a concise plan for protecting the scientific integrity of these ongoing efforts.
A new study involving more than half a million people who were vaccinated in Israel strongly suggests the vaccines have remained effective in preventing symptoms of COVID-19.
As the coronavirus vaccines continue to be distributed across the country, there have been anecdotal reports of people experiencing more side effects after the second dose, but experts say this is a "normal immune response."
While you should consult your doctor if you have concerns, medical experts say the vast majority of prescription drugs will work just as well after you get a COVID-19 vaccine, and they won't diminish the effectiveness of the shot you're getting to ward off the coronavirus.
Biden administration officials, pharmaceutical companies and scientists are racing to get ahead of a coronavirus that has become a more aggressive shape shifter than many expected.
As the coronavirus vaccines are rolled out across the country, there have been some reports of fully vaccinated people still contracting COVID-19, and experts want to assure people the vaccines are still highly effective.
Experts weigh in on the latest iteration of pods or bubbles, which aim to provide social interaction as people become fully vaccinated.
Technical issues and relying on the honor system are some of the reasons why ineligible people are getting vaccines across the country.
The news about Janssen Pharmaceuticals' coronavirus vaccine was disappointing. But those headline efficacy figures obscure an important point: Against the most serious cases, the shot was very effective.
Dr. William Moss, executive director of the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health, provides a coronavirus and vaccine update.
More than a month since the U.S. first began administering COVID-19 vaccines, many people who were not supposed to be first in line have received vaccinations.